Printer Friendly
The Free Library
14,505,807 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Palomar Medical Technologies licenses Massachusetts General Hospital's hair removal technology; Prepared to enter $1 billion market.


BEVERLY, Mass.--(BUSINESS WIRE)--Sept. 8, 1995--Palomar Medical Technologies Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
: PMTI PMTI Potomac Massage Training Institute
PMTI Project Management Training Institute
) announced today it has signed an exclusive, perpetual worldwide licensing agreement with the Massachusetts General Hospital Massachusetts General Hospital Health care The major teaching hospital for Harvard Medical School, widely regarded as one of the best health care centers in the world  (MGH MGH Massachusetts General Hospital
MGH McGraw-Hill Companies
MGH Montreal General Hospital (Montreal, Canada)
MGH Monumenta Germania Historica
MGH May Go Home
MGH Minneapolis General Hospital
) to market its patent pending technology for a laser-based hair removal system.

Under this agreement Palomar obtains access to existing MGH clinical data demonstrating the safety and efficacy of their hair removal system. Palomar will submit this clinical data within 90 days for Food and Drug Administration (FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
) review. Palomar anticipates FDA clearance and market introduction of the MGH system in the first quarter of 1996.

The company has also entered into a four (4) year research agreement with MGH to continue the laboratory and clinical investigation of laser hair removal Epilation performed by laser was performed experimentally for about 20 years before it became commercially available in the mid 1990s. Intense Pulsed Light (IPL) epilators, though technically not a laser, use xenon flash lamps that emit full spectrum light. . Through this research program, Palomar will have access to the most advanced understanding of this process and have ready access to the technology necessary for continuing product improvement. The research will be conducted at MGH's Wellman Laboratories of Photomedicine under the direction of R. Rox Anderson R. Rox Anderson, is an interdisciplinary researcher in photomedicine, the combination of the physics of light with medicine. Anderson is the director of the Wellman Center for Photomedicine , M.D., a world renown authority on the use of lasers in medicine.

"These agreements with MGH perfectly position Palomar to enter the $1 billion plus hair removal market. The company is ideally situated for rapid growth as its infrastructure is well in place with the following operating subsidiaries: Spectrum Medical Technologies Inc., Natick, MA, the product leader, is responsible for marketing and sales of the ruby laser ruby laser Dermatology A high-speed laser used for hair removal and permanent hair reduction over large areas of the body. See Laser.  system. Star Medical Technologies Inc. of Pleasanton, CA, a leader in high energy pulsed diode lasers, will concentrate on the next generation hair removal laser which we anticipate to be a diode device, and Dynaco of Tempe, AZ is responsible for product manufacturing. With this infrastructure and our tie to MGH, we feel that Palomar is well positioned for rapid entry into the hair removal market," said Michael Smotrich, PhD, Palomar's president.

Dr. R. Rox Anderson, in commenting on the research agreement with Palomar said, "The use of lasers in hair removal is exciting, new, and important for medicine. Using the world's oldest type of laser, basic principles known for over a decade and some new ideas on light delivery, Dr. Melanie Grossman and I have shown in a limited number of people that hair removal is feasible and safe. The next steps are to optimize the process and understand the influence of factors such as hair growth cycle, skin color and hair color."

Palomar Technologies Inc. is engaged in the development, production, marketing and sales of minimally invasive medical devices for cardiovascular and dermatological applications and develops and manufactures electronic products.

CONTACT: Palomar Medical Technologies Inc.

Joseph P. Caruso, 508/921-9300

or

Ronald Trahan Associates Inc.

Ron Trahan, 508/651-1180

or

KCSA KCSA Krannert Center Student Association
KCSA Kentucky Crushed Stone Association (Frankfort, KY)
KCSA Kyiv City State Administration
KCSA Kalamazoo Christian School Association
KCSA Kentucky-Canadian Studies Association
 

Joseph A. Mansi/Leslie A. Schupak

212/682-6300, ext. 205/207
COPYRIGHT 1995 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1995, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Sep 8, 1995
Words:458
Previous Article:McAfee Achieves 76% Worldwide Anti-Virus Marketshare; Consistently High Detection Rates And Unrivaled Customer Support Fuel Marketshare Growth;...
Next Article:Wall Street Journal adds weekly real estate page.
Topics:



Related Articles
Frying the follicles: laser hair removal becoming big profit center for cosmetic surgeons. (Los Angeles, CA's hair removal clinics)
LUMENIS GETS JAPANESE GOVERNMENT IMPORT APPROVAL.
East L.A. hospital acquired as Catholic operator leaves town. (Health Care).(Brief Article)
Hair removal. (Product Marketplace).(Palomar EsteLux[TM] Pulsed Light System from Palomar Medical Technolgies Inc. )(Brief Article)
Aesthetic treatments device.(Product Marketplace)(MediLux Pulsed Light System from Palomar Medical Technologies Inc. )(Brief Article)
The impact of preoperative hair removal on surgical site infection.
$100 MILLION FOR HOSPITALS MORE THAN A DOZEN FACILITIES TO GET UPGRADES.(News)
AESTHERx Inc. Woodland Hills.(gets funding from Versant Ventures)(Brief Article)
Biotech success could lead to CytRx payoff, but there's risk.(Company Profile)
McClellan-Palomar provides enticing options.(PRIVATE AVIATION VENDOR SPOTLIGHT)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles